Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$66,783,324
-$2,991,012 QoQ
Shares Held
528,600
+5.6% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#180
of 2,266 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $1,229,733,122 across 9 Drug Manufacturers - General names. GILD ranks #7 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
244,861 | $293,693,653 | |
| 2 | JNJ |
Johnson & Johnson
|
1,050,526 | $266,802,088 | |
| 3 | ABBV |
AbbVie Inc.
|
907,363 | $228,328,825 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,124,149 | $144,453,146 | |
| 5 | AMGN |
Amgen Inc
|
238,092 | $86,217,875 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,167,476 | $67,269,967 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
528,600 | $66,783,324 | |
| 8 | PFE |
Pfizer Inc
|
2,154,713 | $51,885,489 |
All Filings in GILD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,783,324 | 528,600 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $69,774,336 | 500,641 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $57,355,788 | 467,295 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $48,829,122 | 439,902 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $62,635,895 | 564,949 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $84,095,317 | 750,516 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $67,863,592 | 734,693 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $161,645,951 | 1,928,029 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $69,055,416 | 1,006,492 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $73,307,061 | 1,000,779 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $118,610,062 | 1,464,141 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $52,528,143 | 700,936 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $50,727,474 | 658,200 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $37,318,163 | 449,779 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $34,669,063 | 403,833 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $139,585,407 | 2,262,691 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $25,834,293 | 417,963 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $25,070,481 | 421,707 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $47,202,889 | 650,088 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $75,449,664 | 1,080,167 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $74,380,299 | 1,080,167 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $99,652,544 | 1,541,893 | Shares | Sole | 2021-05-17 | |
| 2020-06-30 | $11,819,061 | 153,614 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||